Research Centre, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Canadian Donation Transplant Research Program, Edmonton, Alberta, Canada.
Am J Physiol Renal Physiol. 2021 Sep 1;321(3):F335-F351. doi: 10.1152/ajprenal.00690.2020. Epub 2021 Aug 2.
Ischemia-reperfusion injury (IRI) is a major risk factor for chronic renal failure. Caspase-3, an effector responsible for apoptosis execution, is activated within the peritubular capillary (PTC) in the early stage of IRI-induced acute kidney injury (AKI). Recently, we showed that caspase-3-dependent microvascular rarefaction plays a key role in fibrosis development after mild renal IRI. Here, we further characterized the role of caspase-3 in microvascular dysfunction and progressive renal failure in both mild and severe AKI, by performing unilateral renal artery clamping for 30/60 min with contralateral nephrectomy in wild-type (C57BL/6) or caspase-3 mice. In both forms of AKI, caspase-3 mice showed better long-term outcomes despite worse initial tubular injury. After 3 wk, they showed reduced PTC injury, decreased PTC collagen deposition and α-smooth muscle actin expression, and lower tubular injury scores compared with wild-type animals. Caspase-3 mice with severe IRI also showed better preservation of long-term renal function. Intravital imaging and microcomputed tomography revealed preserved PTC permeability and better terminal capillary density in caspase-3 mice. Collectively, these results demonstrate the pivotal importance of caspase-3 in regulating long-term renal function after IRI and establish the predominant role of PTC dysfunction as a major contributor to progressive renal dysfunction. Our findings demonstrate the pivotal importance of caspase-3 in regulating renal microvascular dysfunction, fibrogenesis, and long-term renal impairment after acute kidney injury induced by ischemia-reperfusion injury. Furthermore, this study establishes the predominant role of peritubular capillary integrity as a major contributor to progressive renal dysfunction after ischemia-reperfusion injury.
缺血再灌注损伤(IRI)是慢性肾衰竭的一个主要危险因素。半胱天冬酶-3(caspase-3)是一种负责执行细胞凋亡的效应因子,在IRI 诱导的急性肾损伤(AKI)的早期阶段,在肾小管周围毛细血管(PTC)中被激活。最近,我们发现 caspase-3 依赖性微血管稀疏在轻度肾 IRI 后纤维化发展中起关键作用。在这里,我们通过对野生型(C57BL/6)或 caspase-3 小鼠进行单侧肾动脉夹闭 30/60 分钟并对侧肾切除术,进一步研究了 caspase-3 在轻度和重度 AKI 中的微血管功能障碍和进行性肾衰竭中的作用。在两种形式的 AKI 中,caspase-3 小鼠尽管初始肾小管损伤更严重,但长期预后更好。3 周后,与野生型动物相比,caspase-3 小鼠的 PTC 损伤减轻,PTC 胶原沉积和α-平滑肌肌动蛋白表达减少,肾小管损伤评分降低。严重 IRI 的 caspase-3 小鼠也表现出更好的长期肾功能保留。活体成像和微计算机断层扫描显示 caspase-3 小鼠的 PTC 通透性保持不变,终末毛细血管密度更好。综上所述,这些结果表明 caspase-3 在调节 IRI 后长期肾功能方面具有重要意义,并确立了 PTC 功能障碍作为进行性肾功能障碍主要原因的主要作用。我们的研究结果表明,caspase-3 在调节缺血再灌注损伤后肾脏微血管功能障碍、纤维化和长期肾功能损害方面具有重要意义。此外,这项研究确立了 PTC 完整性作为缺血再灌注损伤后进行性肾功能障碍主要原因的主要作用。